New search Hide text from Guidelines
B BLOOD AND BLOOD FORMING ORGANSB02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
This group comprises agents, which inhibit fibrinolytic activity.
Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.
| The DDDs are based on treatment of hemorrhage associated with fibrinolysis. |
B02AA Amino acids
B02AB Proteinase inhibitors
Combinations with aprotinin used as local hemostatics are classified in B02BC30.
Last updated: 2020-12-17